Search - tctmd.com

Displaying 1 - 20 of 1068

Sort: Relevancy | Date

Presentation TCT 2025

CASE 4: Aortic Regurgitation and Mitral Regurgitation – Optimal Timing, Role of Surgery, and Staged Approaches

Presenter: Guido Ascione

October 28, 2025

Presentation TCT 2025

CASE 1 - Aortic Stenosis and Mitral Regurgitation – Many Shades of Gray

Presenter: Mahesh V. Madhavan

October 28, 2025

Presentation TCT 2025

TCT 1171: Noncoronary sinus pivot implantation (NCPI) strategy for transcatheter aortic valve replacement with self-expanding valve in pure native aortic regurgitation: a multicenter, registry study from the CCA Database-NTCVR

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 1426: Two Pumps, One Heartbeat: When TAVR Goes South, Impellas Go In

Presenter: Mazhed Kheyrbek

October 28, 2025

Presentation TCT 2025

TCT 1425: Transfemoral Transcatheter Aortic Valve Implantation in Severe Aortic Regurgitation (AR) Due to Aortic Valve Leaflet Perforation: Pure AR-Dedicated Device

Presenter: Ho On Alston Conrad Chiu

October 28, 2025

Presentation TCT 2025

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

Presenter: Chih-Fan Yeh

October 28, 2025

Presentation TCT 2025

TCT 1423: Transcatheter Rescue in the Setting of Endocarditis: Emergency-Use JenaValve in a Non-Surgical Candidate

Presenter: Ankit Gauba

October 28, 2025

Presentation TCT 2025

TCT 1422: TAVR in Severe Aortic Regurgitation Secondary to Acquired Aortico-Left Ventricular Fistula

Presenter: Amr Mohsen

October 28, 2025

Presentation TCT 2025

Dedicated Technologies for Treatment of Aortic Regurgitation

Presenter: Nicholas Stephen Amoroso

October 28, 2025

Presentation TCT 2025

TCT 1189: The Impact of Concomitant Mitral Regurgitation on Cardiovascular Events and Mortality After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

Presenter: Mohammad Reza Movahed

October 28, 2025

Presentation TCT 2025

TCT 1193: Balloon-Expandable Versus Self-Expandable Transcatheter Aortic Valve Replacement In Patients With Concomitant Mitral Regurgitation

Presenter: Temirlan Erkenov

October 28, 2025

Presentation TCT 2025

TCT 1187: Perioperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With Concomitant Mitral Regurgitation Revealing Improving Mitral Regurgitation: A Meta-Analysis

Presenter: Mohammad Reza Movahed

October 28, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Transcatheter Aortic Valve Replacement with Ken-Valve™ in Aortic Regurgitation (Jenscare Scientific): 1- Year Outcomes and Large Annulus Subgroup Analysis

Presenter: Anson Cheung

October 27, 2025

Presentation TCT 2025

The Hanchor Valve for the Treatment of Patients with Severe Aortic Regurgitation (Hanling Medical): 1-Year Results of the Multi-Center HAVE AR Trial

Presenter: Wenzhi Pan

October 27, 2025

Presentation TCT 2025

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

TCT 595: Cardiac Damage Staging in Moderate or Greater Aortic Regurgitation: A New Framework for Risk Stratification

Presenter: Francisco Alexandrino

October 27, 2025

Presentation TCT 2025

Building the Case for an All-Comers RCT in AR: Surgery vs. Transcatheter Replacement

Presenter: Vinod H. Thourani

October 26, 2025

Advertisement

CASE 4: Aortic Regurgitation and Mitral Regurgitation – Optimal Timing, Role of Surgery, and Staged Approaches

CASE 1 - Aortic Stenosis and Mitral Regurgitation – Many Shades of Gray

TCT 1171: Noncoronary sinus pivot implantation (NCPI) strategy for transcatheter aortic valve replacement with self-expanding valve in pure native aortic regurgitation: a multicenter, registry study from the CCA Database-NTCVR

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

TCT 1426: Two Pumps, One Heartbeat: When TAVR Goes South, Impellas Go In

TCT 1425: Transfemoral Transcatheter Aortic Valve Implantation in Severe Aortic Regurgitation (AR) Due to Aortic Valve Leaflet Perforation: Pure AR-Dedicated Device

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

TCT 1423: Transcatheter Rescue in the Setting of Endocarditis: Emergency-Use JenaValve in a Non-Surgical Candidate

TCT 1422: TAVR in Severe Aortic Regurgitation Secondary to Acquired Aortico-Left Ventricular Fistula

Dedicated Technologies for Treatment of Aortic Regurgitation

TCT 1189: The Impact of Concomitant Mitral Regurgitation on Cardiovascular Events and Mortality After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

TCT 1193: Balloon-Expandable Versus Self-Expandable Transcatheter Aortic Valve Replacement In Patients With Concomitant Mitral Regurgitation

TCT 1187: Perioperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With Concomitant Mitral Regurgitation Revealing Improving Mitral Regurgitation: A Meta-Analysis

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Transcatheter Aortic Valve Replacement with Ken-Valve™ in Aortic Regurgitation (Jenscare Scientific): 1- Year Outcomes and Large Annulus Subgroup Analysis

The Hanchor Valve for the Treatment of Patients with Severe Aortic Regurgitation (Hanling Medical): 1-Year Results of the Multi-Center HAVE AR Trial

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

TCT 595: Cardiac Damage Staging in Moderate or Greater Aortic Regurgitation: A New Framework for Risk Stratification

Building the Case for an All-Comers RCT in AR: Surgery vs. Transcatheter Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content